Hartmut Lode

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Lode H M
Clinical impact of antibiotic-resistant Gram-positive pathogens.
Sendzik Judith; Lode Hartmut; Stahlmann Ralf
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
Eisenblätter M; Klaus C; Pletz M W R; Orawa H; Hahn H; Wagner J; Lode H
Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hartmut Lode (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lode H M
Clinical impact of antibiotic-resistant Gram-positive pathogens.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15(3):212-7.
2009: Sendzik Judith; Lode Hartmut; Stahlmann Ralf
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
International journal of antimicrobial agents 2009;33(3):194-200.
2008: Eisenblätter M; Klaus C; Pletz M W R; Orawa H; Hahn H; Wagner J; Lode H
Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(11):1087-92.
2008: Pletz Mathias W; Maus Ulrich; Krug Norbert; Welte Tobias; Lode Hartmut
Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
International journal of antimicrobial agents 2008;32(3):199-206.
2008: Lode Hartmut M
Rational antibiotic therapy and the position of ampicillin/sulbactam.
International journal of antimicrobial agents 2008;32(1):10-28.
2008: Lode Hartmut M; Schmidt-Ionas Malina; Stahlmann Ralf
Gemifloxacin for community-acquired pneumonia.
Expert opinion on investigational drugs 2008;17(5):779-86.
2008: Torres Antoni; Garau Javier; Arvis Pierre; Carlet Jean; Choudhri Shurjeel; Kureishi Amar; Le Berre Marie-Aude; Lode Hartmut; Winter John; Read Robert C;
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(10):1499-509.
2008: de Roux Andrés; Schmöle-Thoma B; Siber G R; Hackell J G; Kuhnke A; Ahlers N; Baker S A; Razmpour A; Emini E A; Fernsten P D; Gruber W C; Lockhart S; Burkhardt O; Welte T; Lode H M
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(7):1015-23.
2008: Lode H
Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. Introduction.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2008;14 Suppl 3():1-2.
2008: Pletz M W; Maus U; Hohlfeld J M; Lode H; Welte T
[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance]
Deutsche medizinische Wochenschrift (1946) 2008;133(8):358-62.
2008: Ott S R; Allewelt M; Lorenz J; Reimnitz P; Lode H;
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.
Infection 2008;36(1):23-30.
2007: Lode H; Torres A; Cockle A
[What are the reasons for our choice? Proofs, recommendations or habit?]
Médecine et maladies infectieuses 2007;37 Spec No 1():17-22.
2007: Klugman K; Lode H
[Complex choices in respiratory tract infections: the search for simple solutions]
Médecine et maladies infectieuses 2007;37 Spec No 1():1.
2007: Lode Hartmut M
Managing community-acquired pneumonia: a European perspective.
Respiratory medicine 2007;101(9):1864-73.
2007: Masterton R; Craven D; Rello J; Struelens M; Frimodt-Moller N; Chastre J; Ortqvist A; Cornaglia G; Lode H; Giamarellou H; Bonten M J M; Eraksoy H; Davey P
Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development.
The Journal of antimicrobial chemotherapy 2007;60(2):206-13.
2007: Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
A prediction model for bacterial etiology in acute exacerbations of COPD.
Infection 2007;35(3):143-9.
2007: Lode Hartmut; Wagner Jutta; Scherübl Hans
The impersonator.
The American journal of medicine 2007;120(3):239-41.
2007: Lode Hartmut; Torres Antoni; Cockle Antony
What drives our choices? Evidence, guidelines or habit?
International journal of antimicrobial agents 2007;29 Suppl 1():S17-22.
2007: Burkhardt Olaf; Lode Hartmut; Welte Tobias; Merker Hans-Joachim
Ultrastructural types of alveolar macrophages in bronchoalveolar lavages from patients with pulmonary sarcoidosis.
Micron (Oxford, England : 1993) 2007;38(6):572-9.
2006: Lode Hartmut; Stahlmann Ralf; Skopnik Heino;
[Rational use of oral antibiotics in adults and school children (children above 6 years). Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy. V.]
Medizinische Monatsschrift für Pharmazeuten 2006;29(12):441-55.
2006: Cantón Rafael; Lode Harmut; Graninger Wolfgang; Milkovich Gary
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
International journal of antimicrobial agents 2006;28 Suppl 2():S115-27.
2006: Blum T; Roth A; Mauch H; Erbes R; Lode H
[Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series]
Deutsche medizinische Wochenschrift (1946) 2006;131(27):1515-20.
2006: Schmitt D V; Leitner E; Welte T; Lode H
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Infection 2006;34(3):127-34.
2006: Sambatakou Helen; Dupont Bertrand; Lode Hartmut; Denning David W
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
The American journal of medicine 2006;119(6):527.e17-24.
2006: Erbes R; Oettel K; Raffenberg M; Mauch H; Schmidt-Ioanas M; Lode H
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;27(6):1223-8.
2006: de Roux A; Ewig S; García E; Marcos M A; Mensa J; Lode H; Torres A
Mixed community-acquired pneumonia in hospitalised patients.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;27(4):795-800.
2006: Schmidt-Ioanas Malina; Lode Hartmut
Treatment of pneumonia in elderly patients.
Expert opinion on pharmacotherapy 2006;7(5):499-507.
2006: Schmidt-Ioanas Malina; Pletz Mathias W R; de Roux Andres; Lode Hartmut
Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines.
Respiratory medicine 2006;100(4):639-47.
2006: Ott S R; Lode H
[Diagnosis and therapy of aspiration pneumonia]
Deutsche medizinische Wochenschrift (1946) 2006;131(12):624-8.
2006: Schmidt-Ioanas M; Bender M; Roth A; Allewelt M; de Roux A; Lode H
[Serologic early diagnosis of pneumonia caused by Mycoplasma pneumoniae]
Deutsche medizinische Wochenschrift (1946) 2006;131(12):613-7.
2006: Worth H; Lode H
[The wide spectrum of modern pneumology]
Deutsche medizinische Wochenschrift (1946) 2006;131(12):605.
2006: de Roux A; Marx A; Burkhardt O; Schweiger B; Borkowski A; Banzhoff A; Pletz M W R; Lode H
Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients.
Vaccine 2006;24(10):1537-42.
2006: Lode Hartmut
[New S3 guideline for therapy of bacterial respiratory tract infections. Renaissance of tetracyclines]
MMW Fortschritte der Medizin 2006;148(1-2):48.
2006: Lode H M; Erbes R; Linnhoff A
[Management of community-acquired pneumonia in the physician's office]
MMW Fortschritte der Medizin 2006;148(1-2):32-5.
2006: Lode Hartmut M
[Uses in in ambulatory and stationary situations. Clinical indications for beta lactams]
Pharmazie in unserer Zeit 2006;35(5):428-31.
2005: Lode H M; Schmidt-Ioanas M
Vasculitis and infection: effects of immunosuppressive therapy.
Clinical nephrology 2005;64(6):475-9.
2005: de Roux A; Lode H
Pneumococcal vaccination.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;26(6):982-3.
2005: Schneider T; Loddenkemper C; Rudwaleit M; Lode H; Zeitz M
[Fever of unknown origin in the 21st century. 2. Non-infectious diseases (autoimmune diseases)]
Deutsche medizinische Wochenschrift (1946) 2005;130(48):2774-8.
2005: Schneider T; Loddenkemper C; Rudwaleit M; Lode H; Zeitz M
[Fever of unknown origin in the 21st century: infectious diseases]
Deutsche medizinische Wochenschrift (1946) 2005;130(47):2708-12.
2005: Schmidt-Ioanas Malina; de Roux Andres; Lode Hartmut
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Current opinion in critical care 2005;11(5):481-6.
2005: Lode H
Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(10):778-87.
2005: Lode H
[Infectious diseases during change]
Deutsche medizinische Wochenschrift (1946) 2005;130(37):2084-88.
2005: Christensen D; Feldman C; Rossi P; Marrie T; Blasi F; Luna C; Fernandez P; Porras J; Martinez J; Weiss K; Levy G; Lode H; Gross P; File T; Ramirez J;
HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(4):554-6.
2005: Pletz Mathias W R; Lode Hartmut
Apoptosis of circulating neutrophils in COPD patients.
Chest 2005;127(4):1464; author reply 1464-5.
2005: Groneberg David A; Poutanen Susan M; Low Donald E; Lode Hartmut; Welte Tobias; Zabel Peter
Treatment and vaccines for severe acute respiratory syndrome.
The Lancet infectious diseases 2005;5(3):147-55.
2005: Rose M; Lode H; de Roux A; Zielen S
[Pneumococcal vaccination in obstructive lung diseases -- what can we expect?]
Deutsche medizinische Wochenschrift (1946) 2005;130(9):461-5.
2005: Allewelt M; Lode H
[Diagnosis of haemoptoe/haemoptysis]
Deutsche medizinische Wochenschrift (1946) 2005;130(9):450-2.
2005: Witt C; Lode H
[Pneumology -- epidemiological changes and structural consequences]
Deutsche medizinische Wochenschrift (1946) 2005;130(9):439.
2005: Pletz M W R; McGee L; Burkhardt O; Lode H; Klugman K P
Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(1):58-60.
2004: Naber C K; Bauhofer A; Block M; Buerke M; Erbel R; Graninger W; Herrmann M; Horstkotte D; Kern P; Lode H; Mehlhorn U; Meyer J; Mügge A; Niebel J; Peters G; Shah P M; Werdan K
[S2 guideline for infectious endocarditis]
MMW Fortschritte der Medizin 2004;146(Suppl 3-4):123-35.
2004: de Roux A; Schmidt N; Rose M; Zielen S; Pletz M; Lode H
Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids.
Respiratory medicine 2004;98(12):1187-94.
2004: Lode H; Eller J; Linnhoff A; Ioanas M;
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;24(6):947-53.
2004: Pletz Mathias W R; Rau Mareike; Bulitta Juergen; De Roux Andres; Burkhardt Olaf; Kruse Guido; Kurowski Michael; Nord Carl E; Lode Hartmut
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
Antimicrobial agents and chemotherapy 2004;48(10):3765-72.
2004: Wutzler P; Kossow K-D; Lode H; Ruf B R; Scholz H; Vogel G E;
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(2):84-91.
2004: Voss M; Allewelt M; Lode H
[Chronic eosinophilic pneumonia]
Deutsche medizinische Wochenschrift (1946) 2004;129(36):1858-60.
2004: File T M; Lode H; Kurz H; Kozak R; Xie H; Berkowitz E;
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
Antimicrobial agents and chemotherapy 2004;48(9):3323-31.
2004: Schneider T; Ulrichs T; Loddenkemper C; Lode H; Zeitz M; Scherübl H
[Intestinal tuberculosis: a clinical and diagnostic challenge]
Deutsche medizinische Wochenschrift (1946) 2004;129(33):1747-52.
2004: Lode H; Magyar P; Muir J F; Loos U; Kleutgens K;
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(6):512-20.
2004: File Thomas M; Garau Javier; Blasi Francesco; Chidiac Christian; Klugman Keith; Lode Hartmut; Lonks John R; Mandell Lionel; Ramirez Julio; Yu Victor
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Chest 2004;125(5):1888-901.
2004: Lode H; Aronkyto T; Chuchalin A G; Jaaskevi M; Kahnovskii I; Kleutgens K;
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(5):403-8.
2004: Pletz M W R; Ioanas M; de Roux A; Burkhardt O; Lode H
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;23(4):532-7.
2004: de Roux Andrés; Marcos Maria A; Garcia Elisa; Mensa Jose; Ewig Santiago; Lode Hartmut; Torres Antoni
Viral community-acquired pneumonia in nonimmunocompromised adults.
Chest 2004;125(4):1343-51.
2004: Pletz Mathias W R; De Roux Andres; Roth Andreas; Neumann Karl-Heinz; Mauch Harald; Lode Hartmut
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
Antimicrobial agents and chemotherapy 2004;48(3):780-2.
2004: Ioanas Malina; Lode Hartmut
Linezolid in VAP by MRSA: a better choice?
Intensive care medicine 2004;30(3):343-6.
2004: Allewelt M; Schüler P; Bölcskei P L; Mauch H; Lode H;
Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(2):163-70.
2004: Zervos Marcus; Mandell Lionel A; Vrooman Peter S; Andrews Charles P; McIvor Andrew; Abdulla Ramzan H; de Caprariis Pascal J; Knirsch Charles A; Amsden Guy W; Niederman Michael S; Lode Hartmut
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
Treatments in respiratory medicine 2004;3(5):329-36.
2003: de Roux Andrés; Lode Hartmut
Recent developments in antibiotic treatment.
Infectious disease clinics of North America 2003;17(4):739-51.
2003: Lode H; Grossman C; Choudhri S; Haverstock D; McGivern J; Herman-Gnjidic Z; Church D
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia.
Respiratory medicine 2003;97(10):1134-42.
2003: Kuhnke A; Lode H
[Problems of pharmacotherapy of infections in the aged]
Der Internist 2003;44(8):986-94.
2003: Lubasch A; Ziege S; Brodersen B; Borner K; Koeppe P; Lode H
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(7):670-7.
2003: Burkhardt Olaf; Merker Hans-Joachim; Shakibaei Mehdi; Lode Hartmut
Electron microscopic findings in BAL of a fire-eater after petroleum aspiration.
Chest 2003;124(1):398-400.
2003: Pletz M W; Petzold P; Allen A; Burkhardt O; Lode H
Effect of calcium carbonate on bioavailability of orally administered gemifloxacin.
Antimicrobial agents and chemotherapy 2003;47(7):2158-60.
2003: Polzin A; Pletz M; Erbes R; Raffenberg M; Mauch H; Wagner S; Arndt G; Lode H
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;21(6):939-43.
2003: Solèr M; Lode H; Baldwin R; Levine J H A; Schreurs A J M; van Noord J A; Maesen F P V; Zehrer M;
Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(3):144-50.
2003: Lubasch Annette; Lück Stefan; Lode Hartmut; Mauch Harald; Lorenz Joachim; Bölcskei Pal; Welte Tobias;
Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitis.
The Journal of antimicrobial chemotherapy 2003;51(3):659-64.
2003: Pletz M W; Preechachatchaval V; Bulitta J; Allewelt M; Burkhardt O; Lode H
ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate.
Antimicrobial agents and chemotherapy 2003;47(3):1129-31.
2003: Burkhardt Olaf; Allewelt Markus; Pletz Mathias Wilhelm Rudolf; Welte Tobias; Lode Hartmut
Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infection.
Scandinavian journal of infectious diseases 2003;35(8):516-8.
2003: Stahlmann Ralf; Lode Hartmut
Fluoroquinolones in the elderly: safety considerations.
Drugs & aging 2003;20(4):289-302.
2002: Lode Hartmut; File Thomas M; Mandell Lionel; Ball Peter; Pypstra Rienk; Thomas Michael;
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
Clinical therapeutics 2002;24(11):1915-36.
2002: Burkhardt Olaf; Borner Klaus; von der Höh Nicolas; Köppe Peter; Pletz Mathias Wilhelm; Nord Carl Erik; Lode Hartmut
Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers.
The Journal of antimicrobial chemotherapy 2002;50(5):707-12.
2002: Mainz Dagmar; Borner Klaus; Koeppe Peter; Kotwas Jochen; Lode Hartmut
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.
The Journal of antimicrobial chemotherapy 2002;50(5):699-706.
2002: Lode H; Allewelt M
Role of newer fluoroquinolones in lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 2002;50(1):151-4.
2002: Vogel Friedrich; Scholz Horst; al-Nawas B; Elies W; Kresken M; Lode H; Müller O; Naber K G; Petersen E; Shah P; Sörgel F; Stille W; Tauchnitz C; Trautmann M; Ullmann U; Wacha H; Wiedemann B;
[Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy.]
Medizinische Monatsschrift für Pharmazeuten 2002;25(6):193-204.
2002: Lode H; Allewelt M
Role of newer fluoroquinolones in lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 2002;49(5):709-12.
2002: Lode Hartmut
Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
International journal of clinical practice. Supplement 2002;(125):10-17; discussion 37-9.
2002: Grysczyk H; De Roux A; Grassot A; Mauch H; Lode H
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia]
Deutsche medizinische Wochenschrift (1946) 2002;127(10):492-6.
2002: Denning David W; Ribaud Patricia; Milpied Noel; Caillot Denis; Herbrecht Raoul; Thiel Eckhard; Haas Andrea; Ruhnke Markus; Lode Hartmut
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(5):563-71.
2002: Lode H; Garau J
Improving care for patients with respiratory tract infections.
Journal of chemotherapy (Florence, Italy) 2002;14 Suppl 2():22-8.
2002: Burkhardt Olaf; Borner Klaus; Stass Heino; Beyer Gerrit; Allewelt Markus; Nord Carl Erik; Lode Hartmut
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.
Scandinavian journal of infectious diseases 2002;34(12):898-903.
2001: Allewelt M; Lode H
[Diagnosis and therapy of abscess forming pneumonia]
Therapeutische Umschau. Revue thérapeutique 2001;58(10):599-603.
2001: Borner K; Borner E; Lode H
Determination of linezolid in human serum and urine by high-performance liquid chromatography.
International journal of antimicrobial agents 2001;18(3):253-8.
2001: Lode H
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
International journal of antimicrobial agents 2001;18(3):199-209.
2001: Gastmeier P; Beck K D; Lode H
[Respiratory filters and pneumonia: many unresolved questions]
Deutsche medizinische Wochenschrift (1946) 2001;126(30):835-9.
2001: Raffenberg M; Szymanski T; Lubasch A; Erbes R; Wagner S; Weist K; Mansmann U; Lode H
[Infections caused by Stenotrophomonas maltophilia (SMA) in intensive care patients--a prospective case-control study]
Deutsche medizinische Wochenschrift (1946) 2001;126(18):514-8.
2001: Ruf B R; Lode H
[Status of infectiology in Germany]
Deutsche medizinische Wochenschrift (1946) 2001;126(18):513.
2001: Lubasch A; Erbes R; Mauch H; Lode H
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;17(4):641-6.
2001: Lode H; Erbes R
[Idiopathic pulmonary fibrosis. III. Case report]
Deutsche medizinische Wochenschrift (1946) 2001;126(14):401.
2001: Lode H; Erbes R; Raffenberg M
[Idiopathic pulmonary fibrosis. II. Treatment]
Deutsche medizinische Wochenschrift (1946) 2001;126(14):399-401.
2001: Erbes R; Raffenberg M; Lode H
[Idiopathic pulmonary fibrosis. I. Diagnosis]
Deutsche medizinische Wochenschrift (1946) 2001;126(14):395-8.
2001: Lode H; Erbes R; Geerdes-Fenge H; Raffenberg M; Mauch H
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]
Der Anaesthesist 2001;50(1):46-51.
2001: Lode H; Von der Höh N; Ziege S; Borner K; Nord C E
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora.
Scandinavian journal of infectious diseases 2001;33(12):899-903.
2001: Lode H
Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpoint.
Chemotherapy 2001;47 Suppl 3():24-31; discussion 44-8.
2001: Woske H J; Röding T; Schulz I; Lode H
Ventilator-associated pneumonia in a surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen sampling.
Critical care (London, England) 2001;5(3):167-73.
2000: Geerdes-Fenge H F; Wiedersich A; Wagner S; Lehr K H; Koeppe P; Lode H
Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species.
Antimicrobial agents and chemotherapy 2000;44(12):3478-80.
2000: Glück T; Opal S; Alattar-Mantis J; Weitzel T; Lode H; Schölmerich J
Differences between American and German medical students and physicians in knowledge of infectious diseases.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(11):868-70.
2000: Lode H; Erbes R; Geerdes-Fenge H; Raffenberg M; Mauch H
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]
Der Internist 2000;41(11):1170, 1173-6, 1178-9.
2000: Lubasch A; Keller I; Borner K; Koeppe P; Lode H
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers.
Antimicrobial agents and chemotherapy 2000;44(10):2600-3.
2000: Ziege S U; Geerdes-Fenge H F; Rau M; Buchwald U; Lode H
In vitro effects of interleukin-10, prednisolone, and GM-CSF on the non-specific immune function of human polymorphonuclear leucocytes and monocytes.
European journal of medical research 2000;5(9):369-74.
2000: File T; Schlemmer B; Garau J; Lode H; Lynch S; Young C
Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
Journal of chemotherapy (Florence, Italy) 2000;12(4):314-25.
2000: Beyer G; Hiemer-Bau M; Ziege S; Edlund C; Lode H; Nord C E
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(7):548-50.
2000: Glück T; Geerdes-Fenge H F; Straub R H; Raffenberg M; Lang B; Lode H; Schölmerich J
Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy.
Infection 2000;28(4):227-30.
2000: Panknin H T; Lode H; Kresken M
[Clinical significance of infections in geriatric patients in long-term nursing care facilities]
Krankenpflege Journal 2000;38(5):170-6.
2000: Lubasch A; Lode H
[The role of antibiotic therapy in infectious enteritis]
Der Internist 2000;41(5):494-7.
2000: Lode H; Lubasch A; Raffenberg M; Mauch H
Clinical results in the treatment of respiratory infections with moxifloxacin.
Drugs of today (Barcelona, Spain : 1998) 2000;36(4):245-53.
2000: Drusano G L; Lode H; Edwards J R
Meropenem: clinical response in relation to in vitro susceptibility.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(4):185-94.
2000: Lode H
[Therapy recommendations for sarcoidosis]
Deutsche medizinische Wochenschrift (1946) 2000;125(9):252.
2000: Lubasch A; Lode H
[Antibiotic therapy in cholecystitis, cholangitis and pancreatitis]
Der Internist 2000;41(2 Pt 1):168-74.
2000: Lode H
[Theme issue pneumology]
Deutsche medizinische Wochenschrift (1946) 2000;125(8):205.
2000: Lode H; Raffenberg M; Geerdes-Fenge H; Mauch H
Monotherapy of nosocomial pneumonia.
Seminars in respiratory and critical care medicine 2000;21(1):9-17.
2000: Lode H; Eller J; Raffenberg M; Mauch H
Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6 Suppl 3():87-9.
2000: Edlund C; Beyer G; Hiemer-Bau M; Ziege S; Lode H; Nord C E
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora.
Scandinavian journal of infectious diseases 2000;32(1):81-5.
1999: Lode H
[Infectology. Globalized resistant pathogens and new vaccines]
Deutsche medizinische Wochenschrift (1946) 1999;124(51-52):1553-5.
1999: Lode H
[Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects]
Deutsche medizinische Wochenschrift (1946) 1999;124(48):1459-61.
1999: Stahlmann R; Lode H
[Recent fluoroquinolones. Highly effective weapons for ambulatory therapy]
MMW Fortschritte der Medizin 1999;141(47):35-6.
1999: Gastmeier P; Lode H; Rüden H
[What is the evidence in the prevention ventilator-associated pneumonia? Evaluation of several controversial prevention measures in connection with ventilation and suction systems]
Deutsche medizinische Wochenschrift (1946) 1999;124(42):1241-4.
1999: Lode H
Potential interactions of the extended-spectrum fluoroquinolones with the CNS.
Drug safety : an international journal of medical toxicology and drug experience 1999;21(2):123-35.
1999: Borner K; Hartwig H; Lode H
Determination of trovafloxacin in human body fluids by high-performance liquid chromatography.
Journal of chromatography. A 1999;846(1-2):175-80.
1999: Stahlmann R; Eller J; Lode H
[New understanding in the study of infectious diseases. Report of the 25th Ludwig Heilmeyer Symposium of the Society for the Advancement of Internal Medicine]
Deutsche medizinische Wochenschrift (1946) 1999;124(21):670-3.
1999: Lober S; Ziege S; Rau M; Schreiber G; Mignot A; Koeppe P; Lode H
Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium.
Antimicrobial agents and chemotherapy 1999;43(5):1067-71.
1999: Riecke K; Eller J; Gericke C; Lode H
[Inpatient treatment costs of exacerbated chronic obstructive lung disease]
Pneumologie (Stuttgart, Germany) 1999;53(4):199-206.
1999: Raffenberg M; Geerdes-Fenge H; Müller-Pawlowski H; Petri M; Schaberg T; Loddenkemper R; Lode H
[Invasive and non-invasive home ventilation--changes between 1982 and 1996]
Medizinische Klinik (Munich, Germany : 1983) 1999;94(1 Spec No):18-21.
1999: Buchwald U K; Geerdes-Fenge H F; Vöckler J; Ziege S; Lode H
Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone.
European journal of medical research 1999;4(3):85-94.
1999: Bradley J S; Garau J; Lode H; Rolston K V; Wilson S E; Quinn J P
Carbapenems in clinical practice: a guide to their use in serious infection.
International journal of antimicrobial agents 1999;11(2):93-100.
1999: Lode H; Vogel F; Elies W
Grepafloxacin: a review of its safety profile based on clinical trials and postmarketing surveillance.
Clinical therapeutics 1999;21(1):61-74; discussion 1-2.
1999: Lode H
[Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD]
Der Internist 1999;40(1):114.
1999: Stahlmann R; Lode H
Toxicity of quinolones.
Drugs 1999;58 Suppl 2():37-42.
1998: Stahlmann R; Lode H
Safety of quinolones.
Lancet 1998;352(9136):1313.
1998: Lode H; Borner K; Koeppe P
Pharmacodynamics of fluoroquinolones.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(1):33-9.
1998: Eller J; Ede A; Schaberg T; Niederman M S; Mauch H; Lode H
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.
Chest 1998;113(6):1542-8.
1998: Worth H; Adam D; Handrick W; Leupold W; Lode H; Loos U; Marre R; Mauch H; Schaberg T; Shah P; Sill V; Wettengel R
[Prevention and therapy of bronchial infections. Recommendations of the German Respiratory League of the German Society of Pneumology]
Pneumologie (Stuttgart, Germany) 1998;52(4):232-7.
1998: Lode H M; Schaberg T; Raffenberg M; Mauch H
Nosocomial pneumonia in the critical care unit.
Critical care clinics 1998;14(1):119-33.
1997: Worth H; Adam D; Handrick W; Leupold W; Lode H; Loos U; Marre R; Mauch H; Schaberg T; Shah P; Sill V; Wettengel R
[Prophylaxis and therapy of bronchial infections. Recommendations of the German Airway League of the German Pulmonology Association]
Medizinische Klinik (Munich, Germany : 1983) 1997;92(12):699-704.
1997: Allewelt M; Steinhoff D; Rahlwes M; Vogel-Hartmann H; Höffken G; Schaberg T; Lode H
[Changes in the spectrum of the causative agents of community-acquired pneumonias (1982-1992)]
Deutsche medizinische Wochenschrift (1946) 1997;122(34-35):1027-32.
1997: Zix J A; Geerdes-Fenge H F; Rau M; Vöckler J; Borner K; Koeppe P; Lode H
Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.
Antimicrobial agents and chemotherapy 1997;41(8):1668-72.
1997: Riecke K; Wagner S; Eller J; Lode H; Schaberg T
[Pulmonary melioidosis in a German Southeast Asia tourist]
Pneumologie (Stuttgart, Germany) 1997;51(5):499-502.
1997: Wilson W R; Bouza E; Lode H; Mouton Y
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
Journal of chemotherapy (Florence, Italy) 1997;9 Suppl 2():5-18.
1997: Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1997;10(5):1130-6.
1997: Petri M G; König J; Moecke H P; Gramm H J; Barkow H; Kujath P; Dennhart R; Schäfer H; Meyer N; Kalmar P; Thülig P; Müller J; Lode H
Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.
Intensive care medicine 1997;23(3):317-25.
1997: Lode H; Schaberg T; Raffenberg M
[The therapy of nosocomial pneumonia]
Deutsche medizinische Wochenschrift (1946) 1997;122(4):93-6.
1997: Schaberg T; Lode H
[The diagnosis of nosocomial pneumonia]
Deutsche medizinische Wochenschrift (1946) 1997;122(3):61-4.
1997: Geerdes-Fenge H F; Goetschi B; Rau M; Borner K; Koeppe P; Wettich K; Lode H
Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva.
European journal of clinical pharmacology 1997;53(2):127-33.
1997: Schaberg T; Theilacker C; Nitschke O T; Lode H
Lymphocyte subsets in peripheral blood and smoking habits.
Lung 1997;175(6):387-94.
1996: Erbes R; Wagner A; Schaberg T; Lode H; Mauch H; Witte W
[MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases]
Pneumologie (Stuttgart, Germany) 1996;50(10):706-11.
1996: Schaberg T; Rebhan K; Lode H
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1996;9(10):2026-30.
1996: Lode H; Schaberg T
[Pneumonia]
Pneumologie (Stuttgart, Germany) 1996;50 Suppl 2():592-4.
1996: Lode H; Steinhoff D; Schaberg T; Mauch H
[New pneumonia pathogens, especially Chlamydia pneumoniae and Hantaviruses]
Der Internist 1996;37(9):882-9.
1996: Müller-Pawlowski H; Raffenberg M; Schaberg T; Petri M; Lode H
[Intermittent nasal positive pressure ventilation with a ventilator in accordance with the Medical Device Regulation III (MedGV III). Clinical experiences with the BREAS PV 201 in 19 patients]
Pneumologie (Stuttgart, Germany) 1996;50(8):518-22.
1996: Lode H M
Clinical indications for beta-lactamase inhibitors in comparison to other antibiotics.
International journal of antimicrobial agents 1996;7 Suppl 1():S3-7.
1996: Lode H; Borner K; Koeppe P; Schaberg T
Azithromycin--review of key chemical, pharmacokinetic and microbiological features.
The Journal of antimicrobial chemotherapy 1996;37 Suppl C():1-8.
1996: Steinhoff D; Lode H; Ruckdeschel G; Heidrich B; Rolfs A; Fehrenbach F J; Mauch H; Höffken G; Wagner J
Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(6):958-64.
1996: Adam D; Grimm H; Lode H
Re: A. Bauernfeind et al.: Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens (Infection 23 [1995] 316-321)
Infection 1996;24(3):270-1.
1996: Aubier M; Lode H; Gialdroni-Grassi G; Huchon G; Hosie J; Legakis N; Regamey C; Segev S; Vester R; Wijnands W J; Tolstuchow N
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
The Journal of antimicrobial chemotherapy 1996;37 Suppl A():73-82.
1996: Lode H
Preface.
International journal of antimicrobial agents 1996;6 Suppl():v-vi.
1996: Schülin T; Schaberg T; Lode H
[Therapy of lung abscesses]
Deutsche medizinische Wochenschrift (1946) 1996;121(5):137-8.
1996: Schülin T; Schaberg T; Lode H
[Diagnosis of lung abscesses]
Deutsche medizinische Wochenschrift (1946) 1996;121(5):135-6.
1996: Strauss L G; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
[Use of positron-emission tomography in oncology]
Deutsche medizinische Wochenschrift (1946) 1996;121(7):207-9.
1996: Dreetz M; Hamacher J; Eller J; Borner K; Koeppe P; Schaberg T; Lode H
Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.
Antimicrobial agents and chemotherapy 1996;40(1):105-9.
1996: Schaberg T; Gloger G; Reichert B; Mauch H; Lode H
[Resistant lung tuberculosis in Berlin 1987-1993]
Pneumologie (Stuttgart, Germany) 1996;50(1):21-7.
1996: Lode H
[Sputum gram staining in pneumonia]
Deutsche medizinische Wochenschrift (1946) 1996;121(4):114-5.
1996: Schaberg T; Rau M; Oerter R; Liebers U; Rahn W; Kaiser D; Witt C; Lode H
Expression of adhesion molecules in peripheral pulmonary vessels from smokers and nonsmokers.
Lung 1996;174(2):71-81.
1995: Lode H; Garau J; Grassi C; Hosie J; Huchon G; Legakis N; Segev S; Wijnands G
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1995;8(12):1999-2007.
1995: Rolfs A; Beige J; Finckh U; Köhler B; Schaberg T; Lokies J; Lode H
Amplification of Mycobacterium tuberculosis from peripheral blood.
Journal of clinical microbiology 1995;33(12):3312-4.
1995: Schaberg T; Reichert B; Schülin T; Lode H; Mauch H
Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1995;8(10):1688-93.
1995: Hamacher J; Vogel F; Lichey J; Kohl F V; Diwok K; Wendel H; Lode H
Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group.
The Journal of antimicrobial chemotherapy 1995;36 Suppl A():121-33.
1995: Hof H; Lode H
[A single dosage of aminoglycosides?]
Deutsche medizinische Wochenschrift (1946) 1995;120(25-26):935-7.
1995: Schönfeld N; Schaberg T; Lode H; Loddenkemper R
[Diagnosis of sarcoidosis]
Deutsche medizinische Wochenschrift (1946) 1995;120(19):687-9.
1995: Schaberg T; Schönfeld N; Loddenkemper R; Lode H
[Therapy of sarcoidosis]
Deutsche medizinische Wochenschrift (1946) 1995;120(20):725-7.
1995: Schaberg T; Klein U; Rau M; Eller J; Lode H
Subpopulations of alveolar macrophages in smokers and nonsmokers: relation to the expression of CD11/CD18 molecules and superoxide anion production.
American journal of respiratory and critical care medicine 1995;151(5):1551-8.
1995: Stuht H; Lode H; Koeppe P; Rost K L; Schaberg T
Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Antimicrobial agents and chemotherapy 1995;39(5):1045-9.
1995: Rubinstein E; Lode H; Grassi C
Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(5):1217-28.
1995: Lode H
Cefotaxime for the 1990s.
Diagnostic microbiology and infectious disease 1995;22(1-2):1-3.
1995: Lode H; Schaberg T; Stahlmann R
Selective decontamination of the digestive tract: indications and problems.
Infection 1995;23(3):129-32.
1995: Bittner R C; Schnoy N; Schönfeld N; Grassot A; Loddenkemper R; Lode H; Kaiser D; Krumhaar D; Felix R
[High-resolution magnetic resonance tomography (HR-MRT) of the pleura and thoracic wall: normal findings and pathological changes]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1995;162(4):296-303.
1995: Gramm H J; Hannemann L; Reinhart K; Lode H
[Sepsis: a conception in change. Possibilities and limitations of diagnosis based on clinical criteria]
Deutsche medizinische Wochenschrift (1946) 1995;120(14):498-502.
1995: Müller-Pawlowski H; von Moers A; Raffenberg M; Petri M; Saalfeld S; Lode H
[BiPAP therapy of respiratory disorders in patients with congenital neuromuscular diseases]
Medizinische Klinik (Munich, Germany : 1983) 1995;90(1 Suppl 1):35-8.
1995: Schaberg T; Gloger G; Reichert B; Mauch H; Lode H
Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1995;8(2):278-84.
1995: Schaberg T; Lode H
[Diagnosis of pulmonary infections]
Der Internist 1995;36(2):146-50.
1995: Beige J; Lokies J; Schaberg T; Finckh U; Fischer M; Mauch H; Lode H; Köhler B; Rolfs A
Clinical evaluation of a Mycobacterium tuberculosis PCR assay.
Journal of clinical microbiology 1995;33(1):90-5.
1995: Lode H; Schaberg T; Raffenberg M; Mauch H
Lower respiratory tract infections in the intensive care unit: consequences of antibiotic resistance for choice of antibiotic.
Microbial drug resistance (Larchmont, N.Y.) 1995;1(2):163-7.
1995: Lode H; Hamacher J; Eller J; Schaberg T
Changing role of carbapenems in the treatment of lower respiratory tract infections.
Scandinavian journal of infectious diseases. Supplementum 1995;96():17-23.
1994: Ziegler D; Lode H; Raffenberg M; Schaberg T; Mauch H; Grassot A
[Incompatibility of tuberculosis therapy in a patient with AIDS]
Deutsche medizinische Wochenschrift (1946) 1994;119(50):1728-33.
1994: Schaberg T; Lode H
[Immunization in pneumology]
Pneumologie (Stuttgart, Germany) 1994;48(8):505-10.
1994: Schaberg T; Orzechowski K; Oesterling C; Lode H; Schuppan D
Simultaneous measurement of collagen type-VI-related antigen and procollagen type-III-N-propeptide levels in bronchoalveolar lavage.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1994;7(7):1221-6.
1994: Eller J; Lapa e Silva J R; Poulter L W; Lode H; Cole P J
Cells and cytokines in chronic bronchial infection.
Annals of the New York Academy of Sciences 1994;725():331-45.
1994: Ritz M; Lode H; Fassbender M; Borner K; Koeppe P; Nord C E
Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.
Antimicrobial agents and chemotherapy 1994;38(3):455-9.
1994: Raffenberg M; Schaberg T; Müller-Pawlowski H; Lode H
[Indications for and use of home artificial respiration]
Deutsche medizinische Wochenschrift (1946) 1994;119(6):187-91.
1994: Lode H; Fassbender M; Schaberg T; Borner K; Koeppe P
Comparative pharmacokinetics of the new oral cephalosporins.
Drugs 1994;47 Suppl 3():10-9; discussion 19-20.
1993: Dennhardt R; Gramm H J; Wiegand-Löhnert C; Lode H
[Antimycotic therapy on intensive care units: contra]
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 1993;28(7):453-6.
1993: Lode H
[The treatment of multiply resistant pulmonary tuberculosis]
Deutsche medizinische Wochenschrift (1946) 1993;118(46):1706-7.
1993: Schaberg T; Lode H
[Influenza infection and antibiotic therapy]
Deutsche medizinische Wochenschrift (1946) 1993;118(45):1663.
1993: Eller J M; Schaberg T; Lode H
[The therapy of bronchiectasis]
Deutsche medizinische Wochenschrift (1946) 1993;118(44):1608-10.
1993: Eller J M; Schaberg T; Lode H
[The clinical picture and diagnosis of bronchiectasis]
Deutsche medizinische Wochenschrift (1946) 1993;118(44):1605-7.
1993: Schaberg T; Mauch H; Lode H
[The clinical significance of penicillin-resistant pneumococci]
Deutsche medizinische Wochenschrift (1946) 1993;118(41):1491-7.
1993: Schaberg T; Lode H
[Influenza infection and antibiotic therapy]
Deutsche medizinische Wochenschrift (1946) 1993;118(40):1464.
1993: Günther J; Lode H; Raffenberg M; Schaberg T
Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(9):723-4.
1993: Paulfeuerborn W; Müller H J; Borner K; Koeppe P; Lode H
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
Antimicrobial agents and chemotherapy 1993;37(9):1835-41.
1993: Lode H; Schaberg T; Raffenberg M; Mauch H
Diagnostic problems in lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 1993;32 Suppl A():29-37.
1993: Schaberg T; Rau M; Stephan H; Lode H
Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells.
The American review of respiratory disease 1993;147(6 Pt 1):1507-13.
1993: Fassbender M; Lode H; Schaberg T; Borner K; Koeppe P
Pharmacokinetics of new oral cephalosporins, including a new carbacephem.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(5):646-53.
1993: Schneider T; Jahn H U; Steinhoff D; Guschoreck H M; Liesenfeld O; Mäter-Böhm H; Wesirow A L; Lode H; Ludwig W D; Dissmann T
[A Q fever epidemic in Berlin. The epidemiological and clinical aspects]
Deutsche medizinische Wochenschrift (1946) 1993;118(19):689-95.
1993: Borner K; Borner E; Lode H
Determination of a new cephalosporin, SCE-2787, in serum and urine by high-performance liquid chromatography.
Journal of chromatography 1993;615(1):174-9.
1993: Lode H; Schaberg T
Rational approach to the diagnosis of Pneumocystis carinii pneumonia (PCP)
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1993;6(2):166-8.
1993: Deppermann K M; Lode H
Fluoroquinolones: interaction profile during enteral absorption.
Drugs 1993;45 Suppl 3():65-72.
1992: Geerdes H F; Ziegler D; Lode H; Hund M; Loehr A; Fangmann W; Wagner J
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):991-1002.
1992: Schaberg T; Lauer C; Lode H; Fischer J; Haller H
Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production.
The American review of respiratory disease 1992;146(5 Pt 1):1287-93.
1992: Schaberg T; Lode H
[Therapy of pulmonary mycoses]
Deutsche medizinische Wochenschrift (1946) 1992;117(45):1725-9.
1992: Schaberg T; Mauch H; Lode H
[The clinical picture and diagnosis of pulmonary mycoses]
Deutsche medizinische Wochenschrift (1946) 1992;117(44):1681-4.
1992: Schaberg T; Lode H
[Therapy of urogenital tuberculosis]
Deutsche medizinische Wochenschrift (1946) 1992;117(37):1418-9.
1992: Roller S; Lode H; Stelzer I; Deppermann K M; Boeckh M; Koeppe P
Pharmacokinetics of loracarbef and interaction with acetylcysteine.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(9):851-5.
1992: Bächer K; Schaeffer M; Lode H; Nord C E; Borner K; Koeppe P
Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
The Journal of antimicrobial chemotherapy 1992;30(3):365-75.
1992: Borner K; Borner E; Lode H
Determination of sparfloxacin in serum and urine by high-performance liquid chromatography.
Journal of chromatography 1992;579(2):285-9.
1992: Schaberg T; Lode H
[Ambulant atypical pneumonia: clinical diagnosis and therapy]
Immunität und Infektion 1992;20(4):136-7.
1992: Lode H; Schaberg T; Höffken G
[Chemotherapeutic prevention of infection in invasive interventions in high-risk internal medicine patients]
Der Internist 1992;33(6):418-24.
1992: Boeckh M; Lode H; Höffken G; Daeschlein S; Koeppe P
Pharmacokinetics of roxithromycin and influence of H2-blockers and antacids on gastrointestinal absorption.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(5):465-8.
1992: Adam D; Ferlinz R; Frei R; Geisler L; Knothe H; Lode H; Shah P
[Antibacterial therapy in infectious bronchial diseases. Recommendations of the German League for control of respiratory tract diseases]
Medizinische Monatsschrift für Pharmazeuten 1992;15(4):100-5.
1992: Saathoff N; Lode H; Neider K; Depperman K M; Borner K; Koeppe P
Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
Antimicrobial agents and chemotherapy 1992;36(4):796-800.
1992: Schaberg T; Haller H; Rau M; Kaiser D; Fassbender M; Lode H
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1992;5(4):387-93.
1992: Lode H; Schaberg T; Lebahn H
[Value of serum bactericidal test for the treatment of infection]
Medizinische Klinik (Munich, Germany : 1983) 1992;87(2):94-5.
1992: Lode H; Müller C; Borner K; Nord C E; Koeppe P
Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.
Antimicrobial agents and chemotherapy 1992;36(1):144-9.
1992: Schaberg T; Witt C; Lode H
[Bronchoscopic diagnosis of pneumonia]
Zeitschrift für ärztliche Fortbildung 1992;86(1-2):57-62.
1992: Lode H; Höffken G; Kemmerich B; Schaberg T
Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.
Intensive care medicine 1992;18 Suppl 1():S24-7.
1992: Lode H; Schaberg T
Azithromycin in lower respiratory tract infections.
Scandinavian journal of infectious diseases. Supplementum 1992;83():26-33.
1991: Schaberg T; Lode H
[The antibiotic therapy of community-acquired pneumonias]
Deutsche medizinische Wochenschrift (1946) 1991;116(50):1917-20.
1991: Schaberg T; Lode H
[Clinical aspects and diagnosis of community-acquired pneumonia]
Deutsche medizinische Wochenschrift (1946) 1991;116(49):1877-80.
1991: Vogel F; Lode H
The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.
The Journal of antimicrobial chemotherapy 1991;28 Suppl C():81-6.
1991: Haller H; Schaberg T; Lindschau C; Lode H; Distler A
Endothelin increases [Ca2+]i, protein phosphorylation, and O2-. production in human alveolar macrophages.
The American journal of physiology 1991;261(6 Pt 1):L478-84.
1991: Schaberg T; Eller J; Wernitz S; Küstner U; Lode H
[Pulmonary parasitoses as differential diagnosis of lung tuberculosis]
Zeitschrift für ärztliche Fortbildung 1991;85(19):937-42.
1991: Lode H
The pharmacokinetics of azithromycin and their clinical significance.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(10):807-12.
1991: Schaberg T; Rahn W; Racz P; Lode H
Pulmonary schistosomiasis resembling acute pulmonary tuberculosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1991;4(8):1023-6.
1991: Lichey J; Reschofski I; Dissmann T; Priesnitz M; Hoffmann M; Lode H
Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism.
Klinische Wochenschrift 1991;69(12):522-6.
1991: Schaberg T; Lode H
[Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide]
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1991;46(8):276-9.
1991: Schaberg T; Haller H; Lode H
Evidence for a platelet-activating factor receptor on human alveolar macrophages.
Biochemical and biophysical research communications 1991;177(2):704-10.
1991: Lode H; Schaberg T; Höffken G; Schröder R
[Clinical aspects of endocarditis]
Immunität und Infektion 1991;19(2):42-4.
1991: Lode H
Respiratory tract infections: when is antibiotic therapy indicated?
Clinical therapeutics 1991;13(1):149-56; discussion 148.
1991: Lode H
[Use and risk of antibacterial chemotherapy from the medical point of view]
Infection 1991;19 Suppl 1():S72-3.
1990: Boeckh M; Lode H; Deppermann K M; Grineisen S; Shokry F; Held R; Wernicke K; Koeppe P; Wagner J; Krasemann C
Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.
Antimicrobial agents and chemotherapy 1990;34(12):2407-14.
1990: Lode H
[Current trends in the therapy of respiratory tract infections]
Medizinische Klinik (Munich, Germany : 1983) 1990;85(11):661-4.
1990: Schaberg T; Lode H
[Therapy of tuberculosis]
Deutsche medizinische Wochenschrift (1946) 1990;115(47):1799-802.
1990: Schaberg T; Lode H
[Diagnosis of tuberculosis]
Deutsche medizinische Wochenschrift (1946) 1990;115(47):1795-8.
1990: Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
Quinolone pharmacokinetics and metabolism.
The Journal of antimicrobial chemotherapy 1990;26 Suppl B():41-9.
1990: Lode H; Stahlmann R
Evaluation of safety and tolerance in clinical trials with antimicrobial agents.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(7):530-3.
1990: Saathoff A; Lode H; Hampel B; Deppermann K M; Borner K; Koeppe P
Pharmacokinetics of FCE 22891, a new oral penem.
Antimicrobial agents and chemotherapy 1990;34(6):1001-6.
1990: Lode H
[Infections of the airways--when are antibiotics indicated?]
Pneumologie (Stuttgart, Germany) 1990;44(5):763-6.
1990: Höffken G; Elsing C; Ruhnke M; Franke M; Schrappe-Bächer M; Stellbrink H J; Weiss R; Noack H; Petri M; Lode H
[Randomized comparative study of secondary prevention of Pneumocystis carinii pneumonia in patients with acquired immunologic deficiency syndrome]
Medizinische Klinik (Munich, Germany : 1983) 1990;85 Suppl 2():281-5.
1990: Mainz D; Mülleneisen N; Höffken G; Kemmerich B; Wagner J; Lode H
[Value of diagnostic procedures in fiberoptic bronchoscopy of pulmonary infections]
Pneumologie (Stuttgart, Germany) 1990;44 Suppl 1():471-2.
1990: Lode H; Höffken G; Dissmann T; Schäfer H
[Intensive care problems in AIDS patients]
Pneumologie (Stuttgart, Germany) 1990;44 Suppl 1():407-8.
1990: Lode H
Development of clinically important resistance to quinolones and other antibiotic groups.
The Journal of international medical research 1990;18 Suppl 4():27D-36D.
1990: Lode H; Wiley E; Olschewski P; Sievers H; Wintermantel M; Baetz R; Lebahn K; Reinke M; Wagner J; Borner K
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Scandinavian journal of infectious diseases. Supplementum 1990;68():50-5.
1990: Lode H; Boeckh M; Höffken G; Kühn M; Gaffal H; Borner K; Koeppe P
Comparative pharmacokinetics of glycopeptide antibiotics, and the influence of teicoplanin on granulocyte function.
Scandinavian journal of infectious diseases. Supplementum 1990;72():9-13.
1990: Schade U F; Burmeister I; Engel R; Lode H; Kozka I
The role of 13-hydroxylinoleic acid in the activation of macrophages by lipopolysaccharide.
Advances in experimental medicine and biology 1990;256():361-8.
1990: Lode H; Höffken G; Boeckh M; Mainz D
[Bronchitis and obstructive bronchitis]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1990;96():45-8.
1989: Boeckh M; Höffken G; Lode H
[The spectrum of pulmonary manifestations of aspergillosis]
Deutsche medizinische Wochenschrift (1946) 1989;114(44):1706-9.
1989: Deppermann K M; Lode H; Höffken G; Tschink G; Kalz C; Koeppe P
Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid.
Antimicrobial agents and chemotherapy 1989;33(11):1901-7.
1989: Deppermann K M; Boeckh M; Grineisen S; Shokry F; Borner K; Koeppe P; Krasemann C; Wagner J; Lode H
Combination effects of ciprofloxacin, clindamycin, and metronidazole intravenously in volunteers.
The American journal of medicine 1989;87(5A):46S-48S.
1989: Lode H; Hoffken G; Borner K; Koeppe P
Ciprofloxacin intravenous dose variance.
The American journal of medicine 1989;87(5A):40S-45S.
1989: Kemmerich B; Rahlwes M; Vogel-Hartmann H; Bartmann K; Höffken G; Berntsson E; Ruckdeschel G; Wagner J; Lode H
[Community-acquired pneumonia]
Deutsche medizinische Wochenschrift (1946) 1989;114(39):1471-7.
1989: Lode H; Deppermann N; Schmidt U
[Bioequivalence of an optimized doxycycline preparation]
Arzneimittel-Forschung 1989;39(9):1162-5.
1989: Lode H; Schröder R
[Possibilities for errors in endocarditis therapy]
Der Internist 1989;30(8):492-7.
1989: Müller F; Hund M; Löhr J; Lode H; Wagner J; Fangmann W
[Infection 1979 to 1986. Epidemiology, etiology, clinical aspects and prognosis in 691 patients]
Medizinische Klinik (Munich, Germany : 1983) 1989;84(7):323-8.
1989: Lode H
Pharmacokinetics and clinical results of parenterally administered new quinolones in humans.
Reviews of infectious diseases 1989;11 Suppl 5():S996-1004.
1989: Lode H; Springsklee M
[Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients]
Medizinische Klinik (Munich, Germany : 1983) 1989;84(5):236-41.
1989: Sassella D; Cassinelli G; Corigli R; Dewland P; Hutt V; Lode H; Ballard R C
Urinary recovery and tolerability of FCE 22101 following single intravenous administration under restricted and high fluid intake.
The Journal of antimicrobial chemotherapy 1989;23 Suppl C():197-203.
1989: Kunzendorf U; Keller F; Walz G; Haller H; Offermann G; Borner K; Lode H
Multivariate analysis of aminoglycoside levels in hemodialysis patients.
Chemotherapy 1989;35(1):1-6.
1989: Lode H; Höffken G
Oral candidosis and its role in immunocompromised patients.
Mycoses 1989;32 Suppl 2():30-3.
1989: Lode H
[Frequent errors in antibiotic therapy]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1989;95():400-3.
1989: Lode H; Hampel B; Bruckner G; Koeppe P
The pharmacokinetics of sultamicillin.
APMIS. Supplementum 1989;5():17-22.
1989: Lode H; Höffken G; Borner K; Koeppe P
Unique aspects of quinolone pharmacokinetics.
Clinical pharmacokinetics 1989;16 Suppl 1():1-4.
1988: Lode H
[Quinolones]
Schweizerische medizinische Wochenschrift 1988;118(49):1823-30.
1988: Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
The Journal of antimicrobial chemotherapy 1988;22 Suppl C():73-9.
1988: Höffken G; Lode H; Dissmann T; Ludwig W D; Hunsdiek K F; Krämer A; Hampl H; Zorr B; Mielke M; Bratzke B
[Pulmonary complications in acquired immunodeficiency syndrome. Results of a prospective study]
Deutsche medizinische Wochenschrift (1946) 1988;113(19):755-62.
1988: Lode H
Microbiological and clinical aspects of aspiration pneumonia.
The Journal of antimicrobial chemotherapy 1988;21 Suppl C():83-90.
1988: Kemmerich B; Stahlmann R; Lode H
[Fluoroquinolone. 2. Pharmacokinetics and clinical use]
Deutsche medizinische Wochenschrift (1946) 1988;113(17):693-5.
1988: Stahlmann R; Kemmerich B; Lode H
[Fluoroquinolones. 1. Their chemical structure, mechanism of action and antibacterial activity]
Deutsche medizinische Wochenschrift (1946) 1988;113(16):648-51.
1988: Boeckh M; Lode H; Borner K; Höffken G; Wagner J; Koeppe P
Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers.
Antimicrobial agents and chemotherapy 1988;32(1):92-5.
1988: Lode H
Drug interactions with quinolones.
Reviews of infectious diseases 1988;10 Suppl 1():S132-6.
1988: Hampel B; Lode H; Bruckner G; Koeppe P
Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers.
Drugs 1988;35 Suppl 7():29-33.
1987: Lode H; Wiley R; Höffken G; Wagner J; Borner K
Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
Antimicrobial agents and chemotherapy 1987;31(10):1491-6.
1987: Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
Pharmacokinetics of ofloxacin after parenteral and oral administration.
Antimicrobial agents and chemotherapy 1987;31(9):1338-42.
1987: Keller F; Borner K; Schwarz A; Offermann G; Lode H
Therapeutic aminoglycoside monitoring in renal failure patients.
Therapeutic drug monitoring 1987;9(2):148-53.
1987: Lode H; Kemmerich B; Schäfer H; Grothe R; Hartmann R; Ehret W; Ruckdeschel G
Significance of non-pneumophila Legionella species in adult community-acquired and nosocomial pneumonias.
Klinische Wochenschrift 1987;65(10):463-8.
1987: Höffken G; Rühl H; Seibt H; Meeth A; Lode H; Nekarda H; Wagner I; Horbach I; Rodloff A; Janitschke K
Increased awareness of aspergillosis in acute leukemia patients.
Haematology and blood transfusion 1987;30():535-7.
1987: Harnoss B M; Hirner A; Dibbelt H; Häring R; Rodloff R; Lode H
Perioperative antibiotic prophylaxis in bile-duct interventions: results of two prospective randomized studies.
Chemotherapy 1987;33(4):297-301.
1987: Lode H
Consideration of the uses and risks of co-trimoxazole from the therapeutic point of view.
Infection 1987;15 Suppl 5():S231.
1987: Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
Comparative pharmacokinetics of new quinolones.
Drugs 1987;34 Suppl 1():21-5.
1987: Lode H
[Infection and septic shock. Antibiotic therapy]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1987;93():349-53.
1987: Lode H
Co-trimoxazole from the therapeutic viewpoint.
Infection 1987;15 Suppl 5():S222-6.
1987: Lode H; Grothe H; Schäfer H; Kemmerich B; Ruckdeschel G; Ehret H
[Clinical aspects and prognosis of Legionella infections]
Schriftenreihe des Vereins für Wasser-, Boden- und Lufthygiene 1987;72():15-25.
1986: Keller F; Wagner K; Borner K; Kemmerich B; Lode H; Offermann G; Distler A
Aminoglycoside dosage in hemodialysis patients.
Journal of clinical pharmacology 1986;26(8):690-5.
1986: Stahlmann R; Lode H
[Which factors are increasing the nephrotoxicity of aminoglucoside antibiotics?]
Deutsche medizinische Wochenschrift (1946) 1986;111(37):1409-14.
1986: Borner K; Lode H; Höffken G
Renal elimination of sulfo-ciprofloxacin, a new metabolite of ciprofloxacin.
European journal of clinical microbiology 1986;5(4):476.
1986: Höffken G; Tetzel H; Koeppe P; Lode H
The pharmacokinetics of ticarcillin, clavulanic acid and their combination.
The Journal of antimicrobial chemotherapy 1986;17 Suppl C():47-55.
1986: Borner K; Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R
Liquid chromatographic determination of ciprofloxacin and some metabolites in human body fluids.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1986;24(5):325-31.
1986: Borner K; Höffken G; Lode H; Koeppe P; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reinitz D
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.
European journal of clinical microbiology 1986;5(2):179-86.
1986: Borner K; Lode H
[Biotransformation of selected gyrase inhibitors]
Infection 1986;14 Suppl 1():S54-9.
1985: Höffken G; Tetzel H; Koeppe P; Lode H
Pharmacokinetics and serum bactericidal activity of ticarcillin and clavulanic acid.
The Journal of antimicrobial chemotherapy 1985;16(6):763-71.
1985: Lode H; Höffken G; Kemmerich B
[Bacterial pneumonias]
Der Internist 1985;26(6):311-20.
1985: Höffken G; Borner K; Glatzel P D; Koeppe P; Lode H
Reduced enteral absorption of ciprofloxacin in the presence of antacids.
European journal of clinical microbiology 1985;4(3):345.
1985: Höffken G; Lode H; Prinzing C; Borner K; Koeppe P
Pharmacokinetics of ciprofloxacin after oral and parenteral administration.
Antimicrobial agents and chemotherapy 1985;27(3):375-9.
1985: Harnoss B M; Lode H
[Indications for and results of antibiotic prophylaxis]
Krankenpflege Journal 1985;23(1-2):11-3.
1985: Keller F; Lode H; Offermann G
Antimicrobial therapy in dialysis patients. II. Remaining antibiotics and antimicrobiologic agents.
Blood purification 1985;3(1-3):104-8.
1985: Lode H
Respiratory infection: the disease.
Clinical therapeutics 1985;7 Suppl A():1-18.
1985: Lode H; Glatzel P D
Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
Infection 1985;13 Suppl 1():S25-7.
1985: Hampel B; Feike M; Koeppe P; Lode H
Pharmacokinetics of temocillin in volunteers.
Drugs 1985;29 Suppl 5():99-102.
1985: Harnoss B M; Harnoss C M; Borner K; Lode H; Koeppe P
Biliary elimination of apalcillin in cholecystectomized patients.
Chemotherapy 1985;31(4):266-71.
1985: Borner K; Lode H; Hampel B; Pfeuffer M; Koeppe P
Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.
Chemotherapy 1985;31(4):237-45.
1985: Harnoss B M; Hirner A; Krüselmann M; Häring R; Lode H
Antibiotic infection prophylaxis in gallbladder surgery--a prospective randomized study.
Chemotherapy 1985;31(1):76-82.
1984: Keller F; Maiga M; Neumayer H H; Lode H; Distler A
Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
European journal of drug metabolism and pharmacokinetics 1984;9(3):275-82.
1984: Lode H; Elvers A; Koeppe P; Borner K
Comparative pharmacokinetics of apalcillin and piperacillin.
Antimicrobial agents and chemotherapy 1984;25(1):105-8.
1984: Lüthy R; Knothe H; Lode H; Stalder H; Stille W
[Use of antibiotics in medical practice. Round Table]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1984;90 Pt 1():221-8.
1984: Höffken G; Lode H; Koeppe P; Ruhnke M; Borner K
Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver.
Chemotherapy 1984;30(1):7-17.
1983: Kemmerich B; Lode H; Brückner O
[Diagnosis and antibiotic treatment of infectious diseases in general practice. Results of an inquiry]
Deutsche medizinische Wochenschrift (1946) 1983;108(51-52):1943-7.
1983: Lode H; Harnoss C M; Fangmann B; Loehr A; Wagner J
[Septicemia. Etiology, epidemiology, clinical aspects and prognosis in 446 patients]
Deutsche medizinische Wochenschrift (1946) 1983;108(50):1908-14.
1983: Lode H; Keller F
[Antibiotic therapy in kidney failure]
Die Medizinische Welt 1983;34(47):1356-9.
1983: Lode H; Grothe R; Schäfer H; Ruckdeschel R
[Clinical and prognostic aspects of nosocomial Legionnaires pneumonias]
Praxis und Klinik der Pneumologie 1983;37 Suppl 1():925-6.
1983: Kemmerich B; Schwarz A; Lode H; Offermann G; Dissmann T
[Tuberculosis in terminal renal insufficiency]
Praxis und Klinik der Pneumologie 1983;37 Suppl 1():468-9.
1983: Lode H
Combination therapy with beta-lactam antibiotics.
The Journal of antimicrobial chemotherapy 1983;12(3):200-3.
1983: Kemmerich B; Warns H; Lode H; Borner K; Koeppe P; Knothe H
Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.
Antimicrobial agents and chemotherapy 1983;24(3):333-8.
1983: Kemmerich B; Lode H; Borner K; Belmega D; Jendroschek T; Koeppe P; Goertz G
Biliary excretion and pharmacokinetics of cefoperazone in humans.
The Journal of antimicrobial chemotherapy 1983;12(1):27-37.
1983: Warns H; Lode H; Harnoss C M; Kemmerich B; Koeppe P; Wagner J
Multiple dose pharmacokinetics and therapeutic results with ceftazidime.
The Journal of antimicrobial chemotherapy 1983;12 Suppl A():235-40.
1983: Lode H; Madey V; Dzwillo G; Borner K; Koeppe P
Serum bactericidal activity and kinetics of azlocillin and moxalactam after single and combined administration.
The Journal of antimicrobial chemotherapy 1983;11 Suppl B():121-6.
1983: Lode H; Warns H; Kemmerich B; Knothe H; Koeppe P
Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora.
European journal of clinical microbiology 1983;2(2):116-21.
1983: Lode H; Daschner F
[Gram-negative nosocomial infections. Epidemiology, causative agents, clinical aspects, trends]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1983;72(9):285-9.
1983: Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Antimicrobial agents and chemotherapy 1983;23(3):429-34.
1983: Borner K; Borner E; Lode H; Peters A
Determination of cefmenoxime in human body fluids by high-performance liquid chromatography.
European journal of clinical microbiology 1983;2(1):17-21.
1983: Lode H; Harnoss C M
[Infection from the viewpoint of the infectiologist]
Beiträge zu Infusionstherapie und klinische Ernährung 1983;10():17-24.
1983: Höffken G; Lode H; Kessler H J
[Effect of doxycycline and isoconazole nitrate on human intestinal fungal flora]
Arzneimittel-Forschung 1983;33(2):273-6.
1982: Hampel B; Lode H; Wagner J; Koeppe P
Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage period.
Antimicrobial agents and chemotherapy 1982;22(6):1061-3.
1982: Borner K; Lode H; Elvers A
Determination of apalcillin and its metabolites in human body fluids by high-pressure liquid chromatography.
Antimicrobial agents and chemotherapy 1982;22(6):949-53.
1982: Lode H; Höffken G
[Pharmacokinetic aspects of oral therapy with antibiotics]
Der Internist 1982;23(11):624-31.
1982: Höffken G; Lode H
[Systemic antimycotic treatment]
Deutsche medizinische Wochenschrift (1946) 1982;107(38):1446-50.
1982: Witkowski G; Lode H; Höffken G; Koeppe P
Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.
European journal of clinical microbiology 1982;1(4):233-7.
1982: Lode H
[Therapy of bronchopulmonary infections in adults]
Krankenpflege Journal 1982;20(7):14-9.
1982: Lode H; Harnoss C M; Wagner J; Biamino G; Schröder R
[Infectious endocarditis: clinical findings, therapy and course in 103 patients]
Deutsche medizinische Wochenschrift (1946) 1982;107(25):967-74.
1982: Lode H; Schäfer H; Ruckdeschel G
[Legionnaires' disease: prospective study of its incidence, clinical features and prognosis. (author's transl)]
Deutsche medizinische Wochenschrift (1946) 1982;107(9):326-31.
1982: Lode H; Schäfer H; Schoeller R; Ruckdeschel R
[Clinical picture of Legionnaires' disease (author's transl)]
Infection 1982;10 Suppl 2():S70-3.
1982: Dalhoff A; Gehl A E; Gau W; Lode H
Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
Chemotherapy 1982;28(6):444-53.
1982: Dalhoff A; Gehl A E; Lode H
Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
Chemotherapy 1982;28(5):381-9.
1981: Höffken G; Lode H
[Bronchopulmonary infection in adults. "Banal" infections, primary atypical pneumonia, bacterial pneumonias]
Die Medizinische Welt 1981;32(36):1302-5.
1981: Jendroschek T; Belmega G; Lode H; Kemmerich B; Dzwillo G; Koeppe P; Wagner J
[Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity]
Medizinische Klinik 1981;76(4):102-6, 70.
1981: Lode H; Schäfer H; Ruckdeschel R
[The new pneumonias]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1981;87():196-201.
1980: Lode H; Kemmerich B; Gruhlke G; Dzwillo G; Koeppe P; Wagner I
Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.
The Journal of antimicrobial chemotherapy 1980;6 Suppl A():193-8.
1980: Lode H; Gruhlke G; Hallermann W; Dzwillo G
Significance of pleural and sputum concentrations for antibiotic therapy of bronchopulmonary infections.
Infection 1980;Suppl 1():49-53.
1980: Lode H; Stahlmann R; Dzwillo G; Koeppe P
[Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)]
Arzneimittel-Forschung 1980;30(3):505-9.
1980: Lode H; Tomas W; Koeppe P; Wagner J
Clinical pharmacology of a new ureidopenicillin: Bay K 49999.
Chemotherapy 1980;26(2):81-90.
1980: Lode H; Kemmerich B; Koeppe P; Belmega D; Jendroschek H
Comparative pharmacokinetics of cefoperazone and cefotaxime.
Clinical therapeutics 1980;3(Spec Issue):80-8.
1979: Lode H; Stahlmann R; Koeppe P
Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.
Antimicrobial agents and chemotherapy 1979;16(1):1-6.
1979: Lode H
Penetration of antibiotics into the pleural fluid.
The Journal of antimicrobial chemotherapy 1979;5(2):122-4.
1979: Kraft D; Lode H
Elimination of ampicillin and gentamicin by hemofiltration.
Klinische Wochenschrift 1979;57(4):195-6.
1979: Lode H; Köppe P; Stahlmann R
[Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)]
Infection 1979;7 Suppl 6():600-5.
1979: Lode H; Huettemann U; Huckauf H; Macha H N; Aurich R
Efficacy of reproterol assessed by the acetylcholine provocation test.
Respiration; international review of thoracic diseases 1979;38(5):280-8.
1979: Siegenthaler W; Ahlert G; Knothe H; Linzenmeier G; Lode H; Lüthy R; Marget W; Schenk J; Simon C; Wiedemann B
[Bacterial infections and possibility of oral antibiotic therapy with cephaclor]
Infection 1979;7 Suppl 6():515-36.
1978: Höffken G; Lode H; Koeppe P; Wendt H
[The effect of prednisolone on the resorption of amoxicillin]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1978;(84):967-8.
1978: Lode H; Stahlmann R; Dzwillo G; Koeppe P
[Pharmacokinetic comparative studies on the resorption of 3 new cephalosporins]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1978;(84):964-6.
1978: Lode H; Grunert K; Kemmerich B; Koeppe P
[Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)]
Advances in clinical pharmacology 1978;15():35-44.
1977: Nolte D; Galgóczy G; Lode H; Mándi A; Matthys H; Stresemann E
[A multi-centre study of reproterol, a bronchodilator (author's transl)]
Deutsche medizinische Wochenschrift (1946) 1977;102(16):619-23.
1977: Lode H; Behn B; Langmaack H; Schröder R
[Bacterial endocarditis. Clinical picture, treatment and course in 37 patients (author's transl)]
Deutsche medizinische Wochenschrift (1946) 1977;102(16):599-606.
1977: Lode H; Niestrath K; Koeppe P; Langmaack H
[Pharmacokinetics and clinical experience with 2 new penicillins: azlocillin and mezlocillin]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1977;83():1704-6.
1977: Lode H
[Indications for the monitoring of aminoglycoside serum concentrations in internal medicine (author's transl)]
Infection 1977;5(2):119-20.
1977: Lode H; Niestrath U; Koeppe P; Langmaack H
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)]
Infection 1977;5(3):163-9.
1976: Lode H; Grunert K; Koeppe P; Langmaack H
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
The Journal of infectious diseases 1976;134 SUPPL():S316-22.
1976: Lode H; Grunert K; Koeppe P; Langmaack H
[Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic]
Deutsche medizinische Wochenschrift (1946) 1976;101(36):1312-7.
1976: Lode H; Kemmerich B
[Enzymatic quick determination of aminoglycoside antibiotics in serum]
International journal of clinical pharmacology and biopharmacy 1976;13(1):59-64.
1976: Lode H; Grunert K; Koeppe P; Langmaack H
[Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1976;82 Pt 2():1684-6.
1976: Lode H; Altgelt B; Langmaack H; Schröder R
[Bacterial endocarditis: clinical aspects, therapy and course forms in 36 patients]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1976;82 Pt 2():1063-4.
1975: Lode H; Kemmerich B; Koeppe P; Langmaack H
[Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)]
Deutsche medizinische Wochenschrift (1946) 1975;100(42):2144-50.
1975: Lode H; Kemmerich B; Koeppe P
[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin.]
Antimicrobial agents and chemotherapy 1975;8(4):396-401.
1975: Lode H; Kemmerich B; Langmaack H
[Sisomycin--comparative pharmacokinetic studies and clinical experiences with a new aminoglycoside antibiotic]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1975;81():1646-8.
1975: Lode H
[Studies on the in vitro effects of cephalothin and gentamicin, alone and in combination, on proteus mirabilis and enterococci (author's transl)]
Infection 1975;3(2):83-8.
1975: Lode H; Gebert S; Hendrischk A
Comparative pharmacokinetics and clinical experience with a new cephalosporin-derivative: cefazolin.
Chemotherapy 1975;21(1):19-32.
1974: Lode H; Janisch P; Küpper G; Weuta H
Comparative clinical pharmacology of three ampicillins and amoxicillin administered orally.
The Journal of infectious diseases 1974;129(0):suppl:S156-68.
1974: Lode H; Naumann P
[The in vitro effects of cephalothin, gentamicin and their combination against Proteus mirabilis and Enterococci]
Advances in clinical pharmacology 1974;8():46-50.
1974: Lode H; Janisch P; Küpper G
[Clinical pharmacology of three ampicillins and amoxicillin by oral application]
Advances in clinical pharmacology 1974;7():35-9.
1974: Lode H; Hendrischk A; Gebert S
[Pharmacokinetics and therapeutic experiences with a new cephalosporin derivative: cefazoline]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1974;80():1541-3.
1973: Naumann P; Lode H; Reintjens E
[Combination therapy using penicillin. Methods of analysis and pharmacokinetics of oxacillin and ampicillin administered simultaneously]
Arzneimittel-Forschung 1973;23(2):218-25.
1973: Lode H; Küpper G
[Activity loss of antibiotics in infusion solutions]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1973;79():1438-40.
1973: Lode H; Frisch D; Naumann P
[Oral antibiotic therapy in gastrectomized patients]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1973;79():837-9.
1973: Lode H; Küpper G
[Inactivation of antibiotics in infusion solutions]
Infection 1973;1(3):151-6.
1972: Lode H; Dalhoff A; Naumann P
[Effects of cephalothin, gentamicin, and their combination on the bacterium Proteus mirabilis]
International journal of clinical pharmacology, therapy and toxicology 1972;6(4):346-53.
1972: Lode H; Hüttemann U; Huckauf H
[The effect of oral by administered theophylline on specific airway resistance in airway obstruction]
Arzneimittel-Forschung 1972;22(10):1788-91.
1972: Lode H; Dreher R; Klemens U
[Generalized so-called idiopathic amyloidosis. Clinical and pathologic-anatomical aspects]
Deutsche medizinische Wochenschrift (1946) 1972;97(26):1000-5.
1972: Hüttemann U; Oswald P; Lode H; Huckauf H
[Lung function studies in young apparently health cigarette smokers versus non-smokers]
Respiration; international review of thoracic diseases 1972;29(3):270-87.
1972: Lode H; Hüttemann U; von Wolff C
[The effect of endoscopic abdominal examinations on respiration]
Respiration; international review of thoracic diseases 1972;29(1):61-73.
1971: Hüttemann U; Oswald P; Lode H; Huckauf H
[Changes in pulmonary function of young adults as a result of long time cigarette smoking]
Deutsche medizinische Wochenschrift (1946) 1971;96(46):1791-3.
1971: Hüttemann U; Kunkel G; Lode H; Hass E
[The influence of laevomepromazine and prometazine on respiration in healthy subjects and patients with pulmonary emphysema]
Arzneimittel-Forschung 1971;21(10):1594-8.
1971: Kunkel G; Lode H
[Venous impurity and chronic intestinal diseases]
Schweizerische medizinische Wochenschrift 1971;101(9):319-25.
1971: Lode H; Kunkel G
[Use of polypropylen disposable syringes in blood-gas laboratory]
Zeitschrift für praktische Anästhesie und Wiederbelebung 1971;6(1):58-63.
1971: Lode H; Hüttemann U; von Wolff C
[Influence of abdominal endoscopic examinations on respiration]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1971;77():1114-8.
1970: Lode H
[Antibiotic treatment of broncho-pulmonary infections]
Praxis der Pneumologie vereinigt mit Der Tuberkulosearzt 1970;24(2):65-81.
1969: Lode H; Kunkel G; Hüttemann U
[Paget's disease of the spine with partial paraplegia]
Deutsche medizinische Wochenschrift (1946) 1969;94(11):539-41 passim.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hartmut Lode

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hartmut Lode (preview)

All Publications